PharmTech.com interviewed Jesper who talked about the Testa Center, the effects of the pandemic, and the future.
Felicity Thomas summarized the best parts in this three-minute article.
About the Testa Center
After Jesper had introduced Testa Center as “In the Testa Center, researchers have access to both equipment and expertise to drive their biological production process from lab bench scale to industrial pilot scale.” the article goes on to the effects on the Testa Center given the Covid-19 pandemic.
Jesper answers that groups are still able to run their projects, given that necessary precautions are taken into consideration. He goes on to say “Additionally, we have had several requests for projects related to the fight against COVID-19. One of these projects has just finalized its execution phase in Testa Center. At this point, we cannot share more info due to confidentiality, but we will shortly share more around these activities in our channels.”
The future, ten years down the line?
For Jesper, there seems to be a couple of trends to keep track of in planning the strategic direction for the Testa Center. Jesper summarizes, “New drugs and new molecules (sometimes referred to ‘the new Zoo’) are being discovered at an increasingly higher pace and the complexity of molecules and modes of actions are also getting more complex.”
We highly recommend reading the article in full length at https://www.pharmtech.com/view/mitigating-risk-in-scale-up